Charles Simone, MD
University of Maryland
Nemours/Alfred I. duPont Hospital for Children: Physician: Employee; University of Maryland: Associate Professor, Medical Director of Maryland Proton Treatment Center: Employee
American Society for Radiation Oncology: Chair, Lung Resource Panel; Annals of Palliative Medicine: Editor-in-Chief; Proton Collaborative Group (PCG): Chair, Executive Council; Chair, Lung Committee
Dr. Charles B. Simone, II is the Medical Director of the Maryland Proton Treatment Center and an Associate Professor of Radiation Oncology at the University of Maryland School of Medicine. He is also the Chair of the Clinical Research Committee for the University of Maryland Greenebaum Comprehensive Cancer Center, as well as the Fellowship Director and the Director of the Stereotactic Radiation Therapy Program for the Department of Radiation Oncology. Prior to his appointment at University of Maryland, Dr. Simone was an Associate Professor of Radiation Oncology, Chief of the Thoracic Oncology Service, Co-Director of the Penn Mesothelioma and Pleural Program, and Director of Clinical Research and Operations for the Department of Radiation Oncology at the Hospital of the University of Pennsylvania.
Dr. Simone is a National Institutes of Health, National Science Foundation, and Department of Defense funded investigator who performs clinical and translational research investigating the benefits of proton therapy and stereotactic body radiation therapy as part of multi-modality therapy for thoracic malignancies. He is the Chair of the Proton Collaborative Group Executive Committee, Chair of the PCG Lung Committee, Chair of the American Society for Radiation Oncology Lung Resource Panel Committee, and Chair of the American Society for Photobiology Education Committee. He is appointed to the NRG Oncology Lung Cancer Core Committee; NRG Radiation Oncology Committee; NCI Thoracic Malignancies Steering Committee Mesothelioma Working Group; International Thymic Malignancy Interest Group (ITMIG) Research and Infrastructure Committee; ITMIG Thymic Carcinoma Workgroup; ASTRO Lung Cancer “Blue Ribbon” Panel; American College of Radiation Oncology Scientific Program Committee; American Radium Society Scientific Program Committee; and Particle Therapy Co-Operative Group Scientific Committee. He is also the Editor-in-Chief of Annals of Palliative Medicine and on the Editorial Boards of Journal of Clinical Oncology, Journal of Thoracic Disease, Frontiers in Oncology, and Translational Lung Cancer Research.
Monday, October 22
5:06 PM – 5:23 PM